Keywords: syncor, sales, up, 2nd, quarter, nasdaq-listed, international

Syncor sales up 31% in 2nd quarter

Article | 05 August 2002

Nasdaq-listed Syncor International has posted net sales of $189.3million for second-quarter 2002, a leap of 31% on the like, year-earlier period. Operating ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Cardiolite

Prep kit for Technetium Tc99 Sestamibi for Injection

Go to drug listing